SCHEMBL9902789

SCHEMBL9902789

O=C(Nc1ccc(Nc2ncnc3[nH]ccc(=O)c23)cc1)Nc1cc(C(F)(F)F)ccc1OCCCN1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 8/20 0.54
▸ KDR P35968 10/20 0.53
▸ BRAF P15056 4/20 0.53
▸ RAF1 P04049 3/20 0.53
▸ EGFR P00533 5/20 0.50
▸ AURKA O14965 1/20 0.45
▸ ROCK2 O75116 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LCK P06239 1/20 0.45
▸ FYN P06241 1/20 0.45
▸ RET P07949 1/20 0.45
▸ MET P08581 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ SRC P12931 1/20 0.45
▸ PDGFRA P16234 1/20 0.45
▸ LTK P29376 1/20 0.45
▸ TTK P33981 1/20 0.45
▸ MAP2K2 P36507 1/20 0.45
▸ MAP2K1 Q02750 1/20 0.45
▸ BTK Q06187 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9903084 0.89 BRAF (0.58) EPHX2KDRBRAFRAF1EGFR
SCHEMBL3768545 0.82 BRAF (0.51) KDRBRAFRAF1AURKANTRK2
SCHEMBL3836301 0.80 KDR (0.54) EPHX2KDRBRAFRAF1
SCHEMBL3761347 0.79 CA12 (0.52) KDRBRAFEGFRAURKAROCK2
SCHEMBL3767915 0.76 BRAF (0.43) KDRBRAFRAF1AURKAPDGFRA
SCHEMBL3762938 0.74 RET (0.60) KDRBRAFAURKAROCK2LCK
SCHEMBL2333691 0.74 KDR (0.47) KDRBRAFEGFRALDH1A1LCK
SCHEMBL2333081 0.74 ALDH1A1 (0.48) KDRBRAFALDH1A1RETMAPT
SCHEMBL3767003 0.74 BRAF (0.42) KDRBRAFRAF1EGFRLCK
SCHEMBL3763732 0.72 NTRK1 (0.43) KDRBRAFRAF1EGFRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809629-B1 N,N'-diphenyl urea derivatives suitable for the treatment of tumours, eye diseases, inflammation and diseases of the immune system MERCK PATENT GMBH (DE) 2012-06-13 — — EP claimed
Send feedback